Skip to main content
. 2022 May 17;134:108744. doi: 10.1016/j.yebeh.2022.108744

Table 1.

Demographic distribution of vaccinated patients and all patients.

Variables Anhui Zhifei Longcom Sinopharm (Beijing): BBIBP-CorV (Vero Cells) Second dose N = 58 (75.3) Sinopharm (Wuhan): Inactivated (Vero Cells) Second dose N = 1 (1.2) Sinovac: CoronaVac: Ad5-nCoV two doses N = 16 (20.8) All vaccinated patients All participants
ZF2001 Second dose N = 2 (2.6) N = 77 N = 117
Gender (N/%)
male 0 27 (35) 1 (1.2) 7 (9) 35 (45.5) 57(48)
female 2 (2.6) 31 (40.2) 0 9 (11.7) 42 (54.5) 60(52)



Age
mean/(SD) 14.5 (0.7) 15.01(1.52) 14 14.63(1.71) 14.91 (1.50) 13.214 (3.03)



Educational background
Primary school 34 (29)
Junior high school 2 (2.6) 18 (23.4) 1(1.3) 7 (9) 28 (36.4) 33 (28)
Senior high school 33 (42.9) 8 (10.4) 41 (53.2) 42 (36)
Undergraduate 7 (9) 1 (1.3) 8 (10.4) 8 (7)



Epilepsy characteristics of vaccinated patients
Epilepsy duration years Mean(SD) 1.55 (2.05) 5.79 (3.11) 5 6.88 (2.68) 7.59 (2.67) 5.9(3.50)



Number of antiepileptic drugs
<2 1 (1.30) 44 (57.14) 0 (0) 10 (12.99) 55 (71.43) 86 (73.50)
>=2 1 (1.30) 14 (18.18) 1 (1.30) 6 (7.79) 22 (28.57) 31 (26.50)



Type of seizures
Tonic-clonic seizures 1 (1.30) 6 (7.79) 0 (0) 5 (6.50) 12 (15.58) 22 (18.8)
Focal seizures 1 (1.30) 5 (6.49) 1 (1.30) 4 (5.19) 11 (14.29) 24 (20.5)
Focal to bilateral seizures 0 (0) 45 (58.44) 0 (0) 4 (5.19) 49 (63.64) 51 (43.6)
Others 0 0 0 0 9 (7.7)
Unknown 0 (0) 2 (2.60) 0 (0) 3 (3.90) 5 (5.19) 11 (9.4)



Seizure frequency
None 1 (1.30) 4 (5.19) 1 (1.30) 6 (7.79) 12 (15.58) 34 (29)
Low frequency 1 (1.30) 51 (66.23) 0 (0) 10 (12.99) 62 (80.52) 77 (66)
High frequency 0 (0) 3 (3.90) 0 (0) 0 (0) 3 (3.90) 6 (5)



History of status epilepticus
Yes 1 (1.30) 0 (0) 0 2 (2.60) 3 (3.90) 4(3.40)
No 1 (1.30) 58 (75.32) 1 (1.30) 14 (18.18) 74 (96.10) 113(96.58)